1. Home
  2. RGEN vs CHE Comparison

RGEN vs CHE Comparison

Compare RGEN & CHE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Repligen Corporation

RGEN

Repligen Corporation

HOLD

Current Price

$166.20

Market Cap

8.2B

Sector

Health Care

ML Signal

HOLD

CHE

Chemed Corp

HOLD

Current Price

$432.23

Market Cap

6.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RGEN
CHE
Founded
1981
1970
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Medical/Nursing Services
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
8.2B
6.2B
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
RGEN
CHE
Price
$166.20
$432.23
Analyst Decision
Buy
Strong Buy
Analyst Count
10
4
Target Price
$174.90
$574.25
AVG Volume (30 Days)
618.1K
142.3K
Earning Date
10-28-2025
10-28-2025
Dividend Yield
N/A
0.56%
EPS Growth
N/A
N/A
EPS
0.03
18.95
Revenue
$707,890,000.00
$2,530,634,000.00
Revenue This Year
$17.84
$5.91
Revenue Next Year
$12.44
$6.21
P/E Ratio
$5,383.25
$22.81
Revenue Growth
11.74
6.45
52 Week Low
$102.97
$408.42
52 Week High
$182.52
$623.61

Technical Indicators

Market Signals
Indicator
RGEN
CHE
Relative Strength Index (RSI) 57.69 50.54
Support Level $156.01 $425.50
Resistance Level $167.74 $442.49
Average True Range (ATR) 4.27 7.72
MACD 0.04 1.17
Stochastic Oscillator 81.59 70.13

Price Performance

Historical Comparison
RGEN
CHE

About RGEN Repligen Corporation

Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, or CDMOs, and other life science companies. It sells four main product categories: filtration (including fluid management) is the largest category and was 58% of 2024 revenue, while chromatography, proteins, and process analytics were 19%, 12%, and 9%, respectively. Customers in North America, Europe, and Asia Pacific contributed 44%, 37%, and 19% of revenue, respectively.

About CHE Chemed Corp

Chemed Corp purchases, operates, and divests subsidiaries engaged in diverse business activities to maximize shareholder value. Through its subsidiaries, the company operates in the following segments: VITAS and Roto-Rooter. The VITAS segment generates the majority of the firm's revenue and provides hospice and palliative care services to patients with terminal illnesses through a network of physicians, registered nurses, home health aides, social workers, and volunteers. The Roto-Rooter segment provides plumbing, drain cleaning, water restoration, and related services to residential and commercial customers.

Share on Social Networks: